ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Circulating and Intragraft Donor (HLA)-Specific B Cells Drive Allograft Rejection After Kidney Transplantation

A. Torija1, N. Bolaños1, L. Donadeu1, M. Meneghini2, I. Torres2, A. Gabaldon2, M. Gomà3, E. Crespo1, F. Moreso4, O. Bestard2

1Vall d'Hebron Research Institute (VHIR), Barcelona, Spain, 2Vall d'Hebron University Hospital, Barcelona, Spain, 3Bellvitge University Hospital, Barcelona, Spain, 4Vall d'Heron University Hospital, Barcelona, Spain

Meeting: 2022 American Transplant Congress

Abstract number: 1231

Keywords: B cells, Histology, Kidney transplantation, Rejection

Topic: Basic Science » Basic Science » 04 - B-cell / Antibody /Autoimmunity

Session Information

Session Name: B-cell / Antibody /Autoimmunity

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Besides donor-specific antibodies (DSA), circulating donor(HLA)-specific memory B cells (mBc) have also shown to play a deleterious role driving antibody-mediated rejection (ABMR) in kidney transplant patients. The ubiquitous capacity of allo-specific B cells to circulate through the bloodstream but also infiltrating kidney allografts forming organized tertiary lymphoid structures (TLO), seems to be key for both optimal antigen presentation and DSA production. Here, we characterized cellular immune infiltrates including bulk T, B cells, plasma cells and TLOs-like structures directly within kidney allografts undergoing distinct types of rejections (ABMR, TCMR and Mixed), as well as alloreactive B cells with donor(HLA)-antigen specificity using novel (HLA)monomer-based immune technology to determine distinct graft outcomes.

*Methods: In a cohort of 122 consecutives for cause biopsies showing ABMR (n=48), TCMR (n=41), Mixed (n=17) and 20 pristine kidney biopsies, we examined by immunohistochemistry and digital microscopy the presence of (CD20+) B cells, (CD4+) T helper cells, (CD138+) plasma cells and TLOs enriched aggregates of CD4+CXCR5+, CD20+ with active proliferation (Ki67+). In biopsies showing (CD20+)B-cell clusters, we characterized the presence of donor(HLA)-specific B cells. In parallel, circulating donor(HLA)-specific mBc were also monitored.

*Results: While T cells and Plasma cell infiltrates were more frequent in TCMR or ABMR/Mixed rejection, respectively, 80/106 (80%) of rejecting biopsies displayed graft-infiltrating B cells, regardless the type of rejection (ABMR, TCMR, Mixed) (P=NS). Notably, patients with infiltrating B cells and plasma cells displayed significant worse graft survival (log rank= 0.042 and 0.016, respectively). In 50% of biopsies with B-cell infiltrates, regardless the rejection type, B cells were found to cluster forming TLOs-like structures. Interestingly, within most B-cell clusters donor(HLA)-specific B cells were clearly detected, which paralleled those detected in peripheral blood.

*Conclusions: Our study highlights the ubiquity of donor(HLA)-specific B cells during allograft rejection in kidney transplant patients, which seem to be key to orchestrate graft rejection.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Torija A, Bolaños N, Donadeu L, Meneghini M, Torres I, Gabaldon A, Gomà M, Crespo E, Moreso F, Bestard O. Circulating and Intragraft Donor (HLA)-Specific B Cells Drive Allograft Rejection After Kidney Transplantation [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/circulating-and-intragraft-donor-hla-specific-b-cells-drive-allograft-rejection-after-kidney-transplantation/. Accessed May 30, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences